Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update


You May Also Like

Immuron Reports Record Revenue Exceeding AU$2 million for the FY18 year

Key Highlights: Global Immuron Ltd sales revenue reached an AU$2million milestone continuing its upward ...

Surface Oncology to Present at the Baird 2018 Global Healthcare Conference

CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage ...